Wednesday, July 8, 2026

biotech · Glaucoma · Hepatocellular Carcinoma · AEON

AEON Biopharma

AEON Biopharma trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
Status
Public
HQ
irvine, USA
Employees
11
Programs
9
Drugs
8
Patents
9
Intelligence · Clinical Trials

AEON Biopharma clinical trials

Registry index of 11 ClinicalTrials.gov studies linked to AEON Biopharma programs — each row shows trial ID, program name, phase, status, and indication.

AEON Biopharma trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for AEON Biopharma.

  1. Use of Mitomycin-C (MMC) in trabeculectomy — Approved

    Clinical update
  2. Use of Mitomycin-C in trabeculectomy — Unknown

    Clinical update
  3. ABP-450 — Phase 2

    Clinical update
  4. ET1402L1-ARTEMIS™ T cells -IV — Phase 1

    Clinical update
  5. autologous ET1402L1-CART cells — Phase 1

    Clinical update
  6. ABP-450 — Phase 2

    Clinical update
  7. Mitomycin C — Phase 2

    Clinical update
  8. Provisc — Phase 2

    Clinical update

Trial registry

11 studies